If bloodwork looks good, is staying on a cycle or TRT-plus year-round safe?

No routine blood panel can establish that year-round supraphysiological androgen exposure is safe. Bloodwork measures selected markers at a particular time. Long-term AAS-user studies have identified coronary plaque and impaired cardiac function using imaging, outcomes that are not ruled out by a normal liver panel or a testosterone result within a chosen range.[1]

A prospective HAARLEM imaging study found cardiac changes during androgen use and improvement after cessation in its participants. That does not prove every effect will reverse after repeated or prolonged exposure. Calling a regimen “TRT-plus” or “cruising” also does not define its physiological exposure or clinical appropriateness.[2]

Good monitoring is valuable because it can identify some problems earlier, not because it turns continued exposure into a risk-free activity. Interpretation should include symptoms, blood pressure, cumulative history, and appropriately selected clinical investigations. A reassuring result should answer the question that test can address, rather than being treated as permission to keep increasing or extending a regimen.[1][2]